Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CIGNA Corporation    CI

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Cigna To Buy Great American Supplemental Benefits For $295 Million

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/11/2012 | 12:28am CEST

Cigna Corp. (>> CIGNA Corporation) has agreed to acquire American Financial Group Inc.'s (AFG) Medicare supplement and critical-illness businesses for approximately $295 million in cash, as the managed-care company looks to expand its presence in the individual and seniors markets.

Cigna said its acquisition of Great American Supplemental Benefits Group, one of the largest manufacturers of supplemental health insurance products in the U.S., is expected to close in the second half of 2012.

Great American generated approximately $325 million of revenue last year.

Cigna said the acquisition will expand its individual supplemental offerings to customers in the U.S., bring scaled offerings to the seniors market and extend its direct-to-consumer retail channel.

The deal comes after Cigna bought Medicare carrier HealthSpring Inc. in January for $3.8 billion. The HealthSpring acquisition represented a change in the balance of Cigna, which had primarily focused on employers but will now also be a major source of both Medicare prescription-drug plans and Medicare Advantage coverage, the private insurers' version of the government program.

Cigna has seen its revenue grow in recent quarters, helped by growing membership and a continuing trend of patients using fewer health-care services amid a shaky economy. Last week, the company reported its first-quarter earnings fell 10%, due in part to acquisition costs, though membership growth contributed to better-than-expected revenue.

Meanwhile, American Financial said the deal is expected to be slightly dilutive to its earnings in the short term but will help the company focus on its core businesses.

Cigna shares were up by 11 cents to $45.02 after hours. The stock is up 6.9% so far this year.

-By Nathalie Tadena, Dow Jones Newswires; 212-416-3287; nathalie.tadena@dowjones.com

Stocks mentioned in the article : CIGNA Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CIGNA CORPORATION
08/21 CIGNA : Earns 'certified' status for both physician and hospital quality from na..
08/21 CIGNA : Earns "Certified" Status for Both Physician and Hospital Quality from Na..
08/18 INSIDER TRADING ACTIVITY CIGNA CORPO : CI) – EVP Sold 2,236 shares of Stoc..
08/15 CIGNA : Recognizes Four Midwest Organizations for Commitment to Employee Health ..
08/12 INSIDER TRADING ACTIVITY CIGNA CORPO : CI) – VP Sold 525 shares of Stock
08/11 CIGNA : Recognizes Alliance Residential Company and City of Scottsdale for Commi..
08/11 INSIDER TRADING ACTIVITY CIGNA CORPO : CI) – Insider Sold 3,700 shares of ..
08/10 CIGNA : Foundation Gives $150,000 Grant and Cigna Donates Vehicle for Mobile Den..
08/10 INSIDER TRADING ACTIVITY CIGNA CORPO : CI) – Insider Sold 37,756 shares of..
08/09 CIGNA : Roots for the Home Team with Sponsorship of the Hartford Yard Goats
More news
News from SeekingAlpha
08/21 Fixing Healthcare - Transforming The Role Of Insurance
08/17 The Myth Of General Purpose Wearables
08/17 Obamacare subsidies will continue in August
08/16 U.S. government to make August cost-sharing payments to health insurers
08/16 CBO warns on end to health subsidies
Financials ($)
Sales 2017 41 134 M
EBIT 2017 3 465 M
Net income 2017 2 463 M
Debt 2017 590 M
Yield 2017 0,01%
P/E ratio 2017 18,43
P/E ratio 2018 16,01
EV / Sales 2017 1,10x
EV / Sales 2018 1,03x
Capitalization 44 572 M
Chart CIGNA CORPORATION
Duration : Period :
CIGNA Corporation Technical Analysis Chart | CI | US1255091092 | 4-Traders
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 192 $
Spread / Average Target 8,7%
EPS Revisions
Managers
NameTitle
David Michael Cordani President, Chief Executive Officer & Director
Isaiah Harris Chairman
Eric Palmer Chief Financial Officer
Alan M. Muney Chief Medical Officer
Mark L. Boxer Global Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
CIGNA CORPORATION32.72%44 572
UNITEDHEALTH GROUP19.23%184 496
AETNA INC24.55%51 293
ANTHEM INC32.87%50 159
HUMANA INC21.20%35 736
CENTENE CORP47.74%14 400